Results 301 to 310 of about 1,010,581 (327)

Functionally Active VEGF Fusion Proteins

Protein Expression and Purification, 2001
Angiogenesis is stimulated by vascular endothelial growth factor (VEGF) acting via endothelial cell-specific receptors, such as VEGFR-2, that are overexpressed at the sites of angiogenesis. If VEGF retains activity as a fusion protein with a large N-terminal extension, it would facilitate development of VEGF-based vehicles for receptor-mediated ...
M V, Backer, J M, Backer
openaire   +2 more sources

Construction of Immunoglobulin Fusion Proteins

Current Protocols in Immunology, 2002
AbstractRecombinant DNA technology has allowed the preparation of chimeric genes encoding proteins with novel properties. This unit describes the construction and subsequent testing of genes encoding immunoglobulin chimeras. The first protocol details fusion of a protein (or protein fragment) of interest onto an immunoglobulin constant region using a ...
Diane, Hollenbaugh, Alejandro, Aruffo
openaire   +2 more sources

Bone Morphogenetic Protein and Fusion

Journal of Neurosurgery: Spine, 2007
In their article (Villavicencio AT, Burneikiene S, Nelson EL, et al: Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein– 2. J Neurosurg Spine 3: 436– 443, December, 2005), Villavicencio and colleagues referred to the work by Haid et al., claiming that the fusion rates during ...
Pećina, Marko, Smoljanović, Tomislav, Vukičević, Slobodan   +2 more
openaire   +2 more sources

Albumin Fusion Protein

2016
Albumin fusion technology can improve the blood retention properties of protein-based pharmaceutics that have a short circulation half-life. The procedure consists of fusing the HSA gene with the gene for a therapeutic protein or peptide, thus permitting the existing recombinant protein therapeutics to be reengineered using albumin as a suitable and ...
Toru Maruyama, Victor Tuan Giam Chuang, Masaki Otagiri   +2 more
openaire   +1 more source

“Fc Fusion Proteins”

2018
IgG-based therapeutics has become an increasingly important category of the over two hundred biopharmaceutical products approved in the USA and the EU by late 2014. While a large percentage of this consists of monoclonal antibodies, Fc fusion proteins make up an important class of IgG-based biotechnology drugs.
Carole Heath, Dean Pettit
openaire   +1 more source

Quantitative lmmunoblotting with Fusion Proteins

2003
The development of vaccines against HIV-1 is currently hindered by incomplete understanding of correlates of protective immunity (1-3). Experiments are necessary to measure immune responses in sufficiently fine detail that specific protective responses can be discerned from those that are irrelevant or harmful.
M M, Mitchell, L D, Loomis-Price
openaire   +2 more sources

Fusion Proteins

2011
  +5 more sources

Fusion Proteins

Annals of the New York Academy of Sciences, 1996
LEIF BÜLOW, KLAUS MOSBACH
openaire   +1 more source

Fusion Proteins

2001
openaire   +1 more source

Fusion Proteins

2006
openaire   +1 more source